XTAENURI
Market cap10mUSD
Dec 24, Last price
700.60ILS
1D
0.19%
1Q
-23.41%
IPO
-87.25%
Name
Nur Ink Innovations Ltd
Chart & Performance
P/E
—
P/S
—
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
0k
Net income
-13m
L+110,675.19%
CFO
-9k
L+48.51%
Profile
Nur Ink Innovations Ltd engages in the design, development, production, and sale water-based pigmented inks for digital inkjet printing applications in Israel. It offers Digital Sol-Gel, a water-based pigment inks for digital printing; and white water-based pigment dispersion and functional inks for various applications, markets, and technologies. The company was founded in 2018 and is based in Rosh HaAyin, Israel.
Valuation
Title ILS in thousands, except ratios and share amounts | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
| Income | |||||
Revenues | |||||
Cost of revenue | 12 | 10 | 4 | ||
Unusual Expense (Income) | |||||
NOPBT | (12) | (10) | (4) | ||
NOPBT Margin | |||||
Operating Taxes | 12,848 | ||||
Tax Rate | |||||
NOPAT | (12,861) | (10) | (4) | ||
Net income | (12,861) 110,675.19% | (12) 49.21% | (8) | ||
Dividends | |||||
Dividend yield | |||||
Proceeds from repurchase of equity | |||||
BB yield | |||||
| Debt | |||||
Debt current | |||||
Long-term debt | 6 | 7 | 7 | ||
Deferred revenue | |||||
Other long-term liabilities | 1 | 914 | 62 | ||
Net debt | (5) | (15) | (25) | ||
| Cash flow | |||||
Cash from operating activities | (9) | (6) | (6) | ||
CAPEX | (853) | (2) | (3) | ||
Cash from investing activities | 485 | (14) | (3) | ||
Cash from financing activities | (447) | (385) | 42 | ||
FCF | (12,860) | (10) | (10) | ||
| Balance | |||||
Cash | 10 | 21 | 33 | ||
Long term investments | |||||
Excess cash | 10 | 21 | 33 | ||
Stockholders' equity | 12 | 25 | 35 | ||
Invested Capital | 10 | 11 | 6 | ||
ROIC | |||||
ROCE | |||||
| EV | |||||
Common stock shares outstanding | 5,082 | ||||
Price | 10.57 -66.02% | 31.11 -50.61% | 62.99 | ||
Market cap | 53,717 | ||||
EV | 53,713 | ||||
EBITDA | (11) | (9) | (3) | ||
EV/EBITDA | |||||
Interest | |||||
Interest/NOPBT | |||||